DexCom, Inc.

DXCMNASDAQ • USD
77.94 USD
↘ 0.38 (0.49%)AT CLOSE (03:59 PM EDT)
78.52
↗ 0.59 (0.75%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
78.52
↗ 0.59 (0.75%)
🔴Market: CLOSED

DexCom, Inc. (DXCM) trades at $77.94 per share. There is a divergence between signals — underlying fundamentals rate "Buy" but technical indicators lean "Strong Sell". This is driven by a robust Altman Z-Score, exceptional Return on Equity (38.1%) and a bullish Golden Cross on the moving averages. On valuation, DXCM trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Oct 23, 2026.

Open?$78.68
High?$79.51
Low?$77.82
Prev. Close?$78.32
Volume?5.2M
Avg. Volume?4.2M
VWAP?$78.62
Rel. Volume?1.23x
Bid / Ask
Bid?$77.50 × 100
Ask?$79.75 × 400
Spread?$2.25
Midpoint?$78.63
Valuation & Ratios
Market Cap?29.4B
Shares Out?377.4M
Float?375.9M
Float %?99.6%
P/E Ratio?29.42
P/B Ratio?11.22
EPS?$2.65
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
Employees
11.1K
Market Cap
29.4B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2005-04-14
Address
6340 SEQUENCE DRIVE
SAN DIEGO, CA 92121
Phone: (858) 200-0200
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
100
Momentum?
80
Short Sent.?
59
Piotroski F-Score?6/9Mixed
Altman Z-Score?6.90Safe
Confidence?73%Moderate
Full Fundamental Analysis →
Short InterestModerate
Short % of Float?3.73%Low
Short Interest?14.0M
Days to Cover?3.2
Free Float375.9M
Avg Daily Volume4.4M
Settlement Date2026-09-30
Financial Health
Current Ratio?1.73Adequate
Quick Ratio?1.43Adequate
Cash Ratio?0.47Low
Debt/Equity?0.47Low
ValuationFAIRLY VALUEDvs 5 peers + S&P 500
Score
56/100
P/E?
Peers
67
S&P
35
29.4FAIR▾
P/B?
Peers
17
S&P
17
11.22HIGH▾
P/S?
Peers
33
S&P
23
5.92FAIR▾
P/FCF?
Peers
67
S&P
52
20.9FAIR▾
EV/EBITDA?
Peers
17
S&P
22
21.1HIGH▾
EV/Sales?
Peers
33
S&P
28
5.95FAIR▾
Returns & Efficiency
ROE?
Peers
100
S&P
86
38.1%STRONG▾
ROA?
Peers
100
S&P
88
15.5%STRONG▾
Cash Flow & Enterprise
FCF?$1.4B
Enterprise Value?$29.5B
Fundamentals ratios updated end of day